DSM Sets Ambitious New Targets; to Double Caprolactam Capacity in China

DSM (Heerlen, the Netherlands), today announced major targets under the company's DSM In Motion strategy, which replaces the Vision 2010 program. The company has also announced the sale of its citric acid business to Adcuram (Munich) and the formation of a joint venture with DuPont in surgical biomedical materials. In addition, it will expand its biopharmaceutical joint venture with Crucell. DSM is also seeking partnerships for its anti-infectives business with potential partners in China and India. The company is transforming its organization and culture and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers